Open AccessEffect of hyperbaric oxygen treatment on patients with reduced left ventricular ejection fraction
Author(s) -
J L Vincent,
MarieKristelle Ross,
Neal W. Pollock
Publication year - 2021
Publication title -
diving and hyperbaric medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.389
H-Index - 20
eISSN - 2209-1491
pISSN - 1833-3516
DOI - 10.28920/dhm51.3.256-263
Subject(s) - ejection fraction , medicine , adverse effect , heart failure , hyperbaric oxygen , fraction of inspired oxygen , cardiac function curve , cardiology , intensive care medicine , anesthesia , mechanical ventilation
Hyperbaric oxygen treatment (HBOT) is available to a wide spectrum of patients, many with significant co-morbidities. Considering its effects on cardiac physiology and reports of pulmonary oedema following exposure, concerns exist about the safety of patients with compromised cardiac function. Few studies have described adverse events occurring during HBOT and even fewer reports address events arising in the hours following HBOT. A relation between adverse events and cardiac function has not been established. As medical guidance is limited, we aimed to evaluate the risk for patients with reduced left ventricular ejection fraction (LVEF) receiving HBOT.